Search
![]()
Friend
$12.99
MSRP
112
Pages
Trade Paperback
Format
Oct 2011
On sale
Readers
Readers in the log
No readers yet.
Advanced
- Size
- 7 × 10 in
- Weight
- 13 oz
Loading full dossier
Video overview
Synopsis
A powerful, predatory corporation acquires a valuable asset – Dracula himself! They think they own him, but no one can own the Son of the Dragon. There's a monster in their midst that puts Hannibal Lecter to shame - and he plans to gain his freedom in blood. It's bloodsuckers vs. bloodsucker in the third volume of the new horror graphic novel critics are raving about. Legendary comics writer Kurt Busiek, along with award-winning author Daryl Gregory and sensational artist Scott Godlewski, take you through the dark corridors of the American corporate boardroom and show you vampires aren’t the only kind of bloodsuckers!
Contents
What's inside
Book order unavailable — showing by date
Edit contents
Removed
removed
Edit book order
Issue data: Grand Comics Database (CC BY-SA 4.0)
Collects:
Raw collects (source data)
Other ways to read these issues
Compare contents of any two
Best current item prices, before shipping.
Related editions
No related editions yet.
Selected:
Edit history
Where to buy
We'll email you if it drops that far. Price-drop alerts are now on in Settings.
Price-drop alerts are off, so we won't email you. Turn them on
It's at your price now.
Nothing here yet.
Readers
Comments
Asks
Friends who recommended
Reviews
No reviews yet.
Sign in to write a review.
Sign in to join the conversation.
This thread is locked. New comments and votes are closed.
Discussions are read-only. Reading, reporting and content removal remain available.
No comments yet.
Loading listings…
No listings yet
No one has listed this book for sale or asked for a copy yet. Set the first price — collectors watch new listings here.
Comparable copies suggest around .
Comments
Sign in to join the conversation.
This thread is locked. New comments and votes are closed.
Discussions are read-only. Reading, reporting and content removal remain available.
No comments yet.